• Parkinson’s Research

  Experts say that Nuplazid’s risks for Parkinson’s psychosis don’t appear too high

  Posted by Forum Moderator on June 20, 2018 at 5:56 pm

  Experts appear to split on the risks associated with Nuplazid, Acadia’s approved treatment for psychosis in Parkinson’s disease. Read more here: Nuplazid’s Risks in Treating Parkinson’s Psychosis Don’t Appear Exceptionally High, Experts Say

  
  Have you ever been treated with Nyplazid? Did you experience any side effects?
  

  replied 5 years, 10 months ago 1 Member · 0 Replies
• 0 Replies

Log In to Reply